H. WilliamWilliamTaeuschMD

PubMed

• 43 citations
  Surfactant proteins and anti-surfactant antibodies in sera from infants with respiratory distress syndrome with and without surfactant treatment.
  Shoichi Chida, David S. Phelps, Soll Rf, H W Taeusch
  Pediatrics. 1991-07-01
• 72 citations
  Glucocorticoid prophylaxis for respiratory distress syndrome: a review of potential toxicity.
  H. W. Taeusch
  The Journal of Pediatrics. 1975-10-01
• 259 citations
  Association between maternal diabetes and the respiratory-distress syndrome in the newborn.
  Robert Mf, Raymond K. Neff, John P. Hubbell, Taeusch Hw, Mary Ellen Avery
  The New England Journal of Medicine. 1976-02-12

Journal Articles

• Mel—A Personal Reminiscence  
  Taeusch HW, Frontiers in Pediatrics, 5/1/2014
• Transient Exposure of Pulmonary Surfactant to Hyaluronan Promotes Structural and Compositional Transformations into an Inactivation-Resistant State  
  Lopez-Rodriguez E, Cruz A, Richter R, Taeusch HW, Perez-Gil G, J Biol Chem, 10/11/2013
• Hyaluronan with dextran added to therapeutic lung surfactants improves effectiveness in vitro and in vivo  
  Lu KW, Taeusch HW, Clements JA, Exp Lung Res., 5/1/2013
• Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometer  
  Lopez-Rodriguez E, Ospina OL, Echaide M, Taeusch HW, Perez-Gil J, Biophys J., 10/3/2012
• Meconium impairs pulmonary surfactant by a combined action of cholesterol and bile acids  
  Lopez-Rodriguez E, Echaide M, Cruz A, Taeusch HW, Perez-Gil J, Biophys J., 2/2/2011
• Combined effects of polymers and KL4 peptide on surface activity of pulmonary surfactant lipids  
  Lu KW and Taeusch HW, Biochimica et Biophysica Acta (BBA)-Biomembranes, 6/1/2010
• Reductions of phospholipase A2 inhibition of pulmonary surfactant with hyaluronan  
  Iwanicki J, Lu K, and Taeusch HW, Exp Lung Res., 4/1/2010
• Kinematic viscosities of surfactants with added polymers  
  Lu K, Perez-Gil J, and Taeusch HW, Biochim Biophys Acta., 3/1/2009
• Pulmonary surfactant adsorption is increased by hyaluronan or polyethylene glycol  
  Taeusch HW, Dybbro E, Lu KW, Colloids and Surfaces B: Biointerfaces, 1/1/2008
• Commentary: Surfactant treatment of aspiration-induced lung injury in children  
  Matthay M, Taeusch HW, Pediatr Crit Care Med, 9/1/2007
• A Freeze-fracture TEM and small angle X-ray diffraction study of the effects of albumin, serum and polymers on clinical lung surfactant microstructure  
  Braun A, Stenger P, Warriner H, Zasadzinski J, Lu K, Taeusch HW, Biophysical Journal, 1/1/2007
• Effects of hyaluronan-fortified surfactant in ventilated premature piglets with respiratory distress  
  Wang X, Sun Z, Qian L, Guo C, Yu W, Wang B, Lu KW, Taeusch HW, Sun B, Biology of the Neonate, 1/1/2006
• Polyethylene glycol-surfactant for lavage lung injury in rats  
  Dehority W, Lu KW, Clements JA, Goerke J, and Taeusch HW, Pediatric Research, 11/1/2005
• Hyaluronan decreases surfactant inactivation in vitro  
  Lu K, Goerke J, Clements JA, Taeusch HW, Pediatric Research, 1/1/2005
• Dextran or polyethylene glycol added to curosurf for treatment of meconium lung injury in rats  
  Lu KW, Robertson B, Taeusch HW, Biology of the Neonate, 1/1/2005
• Hyaluronan reduces surfactant inhibition and improves rat lung function after meconium injury  
  Lu KW, Goerke J, Clements JA, Taeusch HW, Pediatric Research, 1/1/2005
• Inactivation of pulmonary surfactant by serum: mechanisms of reduced adsorption and its reversal by hydrophilic polymers: Experimental  
  Taeusch HW, Bernadino de la Serna J, Alonso C, Perez-Gil J, Zasadzinski J, Biophysical Journal, 1/1/2005
• Inactivation of pulmonary surfactant by serum: mechanisms of reduced adsorption and its reversal by hydrophilic polymers: Theory  
  Zasadzinski J, Alig T, Alonso C, Bernardino de la Serna J, Perez-Gil, J, Taeusch HW, Biophysical Journal, 1/1/2005
• Polymer depletion forces and surfactant adsorption  
  Zasadzinski J and H. W. Taeusch, Polymer Preprints, 1/1/2005
• Ionic and nonionic polymers can prevent surfactant inactivation  
  Lu K, Taeusch HW, Acta Pharmacol Sin., 1/1/2003
• Finding the optimal surfactant for treatment of pediatric lung diseases  
  Taeusch HW, Lu K, Shanghai International Pediatric Symposium, 10/1/2002
• Pain after Mogen or PlastiBell Circumcision  
  Taeusch HW, Martinez AM, Partridge JC, Sniderman S, Armstrong-Wells, J, Fuentes-Afflick, E, Journal of Perinatology, 1/1/2002
• Variation in mortality and intraventricular hemorrhage in Pacific Rim nurseries  
  Martinez AM, Taeusch HW, Yu V, Tan KW, Yeung CY, Lu JH, Nishida H, Boo NY, Journal of Paediatrics and Child Health, 1/1/2002
• Polyethylene glycol/surfactant mixtures improve lung function after HCl and endotoxin lung injuries  
  Lu KW, Taeusch HW, Robertson B, Goerke J, Clements JA, Amer Rev Resp and Crit Care Med., 1/1/2001
• Inactivation of pulmonary surfactant and the treatment of acute lung injuries  
  Taeusch HW and Keough KMW, Pediatric Pathology and Molecular Medicine, 1/1/2001
• Join now to see all

Books/Book Chapters

• Avery’s Diseases of the Newborn 
  Chapter: Pulmonary surfactant treatment. 
  Taeusch, HW, Ramirez, D, and Laing, IEditors: H.W.Taeusch, R. Ballard, and C. Gleason.WB Saunders, Philadelphia, PA2005
• Avery's Diseases of the Newborn 
  Editors: Taeusch HW, Ballard R, C Gleason (Taeusch senior editor for Fifth Sixth, Seventh and current Eighth Edition).WB Saunders, Philadelphia, PA2004
• Chronic Lung Disease of Early Infancy 
  Chapter: Bronchopulmonary Dysplasia: Clinical Risk Factors and Associated Clinical Conditions. 
  Martinez A, Dargaville P, Taeusch HWEditors: Exec. Editor: C. Lenfant.Marcel Dekker, Inc., New York2000
• Pediatric and Neonatal Tests and Procedures 
  Taeusch HW, Christiansen R, Buescher ESWB Saunders, Philadelphia, PA1996
• Surfactant Therapy for Lung Disease 
  Editors: Robertson B and Taeusch HW, eds. Claude Lenfant, Series editor.Marcel Dekker, NY1995
• Surfactant Therapy for Lung Disease 
  Chapter: Clinical problems in surfactant treatment of RDS. 
  Boncuk P and Taeusch HWEditors: C. Lenfant, series editor. B. Robertson and HW Taeusch, volume editor.Marcel Dekker, NY1995
• Pulmonary Problems in the Perinatal Period 
  Chapter: Respiratory Distress Syndrome. 
  Taeusch HW and Boncuk PEditors: Victor Yu.WB Saunders (Bailliere Tindall, Ltd), London1995
• Surfactant Replacement Therapy 
  Chapter: Surfactant proteins and surfactant therapy. 
  Taeusch HW, Waring AJAssociates in Medical Marketing, Newton, PA1993
• Current Pediatric Therapy 
  Chapter: Neonatal Resuscitation. 
  Bloom R, Taeusch HWW.B. Saunders, Philadelphia1993
• Pulmonary Surfactant 
  Chapter: Pathophysiology of neonatal surfactant insufficiency: clinical aspects. 
  Walther F, Taeusch HWEditors: B Robertson, L van Golde, J Batenburg.Elsevier, AmsterdamEdition 2nd,1992
• Tufts University Reports on Neonatal Respiratory Distress 
  Chapter: New approaches to surfactant therapy. 
  Page 3 - 12Walther F, Taeusch WEditors: I Frantz, Ross Labs.1991
• The Amphipathic Helix 
  Chapter: Amphipathic helical segments in lung surfactant proteins. 
  Waring A, Gordon L, Bruni R, Taeusch WEditors: R. Epand..CRC Press, Baton Rouge1991
• Proc Eleventh Amer Peptide Symposium 
  Chapter: Biophysical and structural properties of a pulmonary surfactant peptide in phospholipid dispersions. 
  Page 694 - 696Waring A, Taylor L, Simatos G, Keough K, Taeusch WEditors: J River, G Marshall.1990
• Surfactant Treatment of Lung Diseases. Report of the 96th Ross Conference on Pediatric Research 
  Editors: Jobe A and Taeusch HW.Ross Labs, Columbus, OH1988
• Follow Up Management of the High Risk Infant 
  Chapter: Primary care for the NICU graduate. 
  Cohen L, Taeusch HWEditors: HW Taeusch and M Yogman.Little, Brown and Company, Boston1987
• Follow Up Management of the High Risk Infant 
  Chapter: Severe perinatal asphyxia. 
  Becker M, Taeusch HWEditors: HW Taeusch and M Yogman.Little, Brown and Company, Boston1987
• Follow Up Management of the High Risk Infant 
  Chapter: Treatment of apneic spells after discharge. 
  Taeusch HW, MandellEditors: HW Taeusch and M Yogman.Little, Brown and Company, Boston1987
• Follow Up Management of the High Risk Infant 
  Chapter: Mechanics of infant follow up programs. 
  Taeusch HW, Ware JEditors: HW Taeusch and M Yogman.Little, Brown and Company, Boston1987
• Follow Up Management of the High Risk Infant 
  Chapter: Discharge planning. 
  Colangelo A, Vento T, Taeusch HWEditors: HW Taeusch and M Yogman.Little, Brown and Company, Boston1987
• Follow Up Management of the High Risk Infant 
  Editors: Taeusch HW and Yogman MY.Little, Brown and Company, Boston1987
• Clinical Management of the LBW Infant 
  Chapter: Prenatal approaches to RDS: an update. 
  Page 86 - 92Taeusch HW, Torday J, Smith BEditors: A Huch, R Huch, G Duc, G Rooth.Georg Thieme Verlag, Stuttgart, New York1982
• Seminars in Respiratory Medicine 
  Chapter: Management of hyaline membrane disease. 
  Page 106 - 122Taeusch HW, Chernick VBrian Dekker, New York1979
• Clinics in Perinatology 
  Chapter: Pharmacologic control of fetal lung development. 
  Page 243 - 256Brown ER, Torday JS, Taeusch HW1978
• Intensive Care in the Newborn 
  Chapter: Regulation of alveolar surface-active materials in late fetal life and the perinatal period in rabbits and sheep. 
  Lawson EE, Brown ER, Taeusch HWEditors: Stern L, Oh W, Friss-Hansen B. Massan.Edition 2nd,1978
• Development of the Lung 
  Chapter: Regulation of pulmonary alveolar development in late gestation and the perinatal period. 
  Page 399 - 418Taeusch HW, Avery MEEditors: A Hodson.Marcel Dekker, New York1975
• Join now to see all

Abstracts/Posters

• Surface adsorption of fluorescently labeled surfactants mixed with polymers in multiwell microplates.
  Taeusch HW, Lu, KW, Echaide M, Perez-Gil, J, American Thoracic Society, 1/1/2009
• Viscosity of clinical surfactants with added polymers.
  Lu K and Taeusch HW, American Thoracic Society, 6/1/2008
• Infasurf vs. Survanta for treatment of experimental meconium aspiration pneumonia.
  Sacks Z, Iwanicki J, Lu K, Taeusch HW, Western Society of Pediatric Research, 2/1/2008
• Hyaluronan decreased pulmonary surfactant inactivation by phospholipase A2.
  Iwanicki JL, Lu KW, Taeusch HW, Amer J Resp Crit Care Med., 4/1/2007
• Hyaluronan decreases pulmonary surfactant inactivation by phospholipase A2 in vitro.
  Iwanicki JI, Lu KW, Taeusch HW, Journal of Investigative Med., 1/1/2007
• The physics of ARDS and polymer inhibition reversal.
  Zasadzinski J, Stenger P, Fernsler J, Taeusch, HW, International Congress of Respiratory Biology, 8/13/2006
• Relative effects of hyaluronan, dextran, or polyethylene glycol on therapeutic surfactants.
  Taeusch HW, Lu KW, Stein A, Stenger PS, Zasadzinski JA, Proceedings of the American Thoracic Society, 1/1/2006
• Pulmonary surfactant adsorption is increased by hyaluronan or polyethylene glycol.
  Taeusch HW, Lu KW, Pediatric Research, 1/1/2006
• Additive effects of KL4 and polymers for prevention of surfactant inhibition.
  Lu KW, Taeusch HW, Euro J Pediatrics, 1/1/2006
• Hyaluronan-fortified porcine surfactant improves ventilation efficiency and prevents inflammatory injury in premature piglet lungs.
  Wang X, Sun Z, Qian L, Guo C, Yu W, Wang W, Lu K, Taeusch HW, Sun B, American Journal of Respiratory & Critical Care Medicine, 1/1/2005
• Variability of human sera for surfactant inactivation.
  Iwanicki J, Matthay M, Lu KW, Taeusch HW, J of Investigative Med, 1/1/2005
• Spreading of pulmonary surfactants with and without subphase inhibitors and polymers.
  Taeusch HW, Bernardino de la Serna J, Alonso C, Zasadzinski J, Perez-Gil J, American Chemical Society, Anaheim, 3/28/2004
• X-ray diffraction studies of bulk replacement lung surfactants: implications for surfactant failure in ARDS.
  Warriner HE, Ngo A, Taeusch HW, Zasadzinski JA, American Chemical Society, Anaheim, 3/28/2004
• Beneficial effects of adding hyaluronan to pulmonary surfactant.
  Lu K, Goerke J, Clements JA, Taeusch HW, American Journal of Respiratory and Critical Care Medicine, 1/1/2004
• Spreading of pulmonary surfactants with and without subphase inhibitors and polymers.
  Taeusch HW, Bernadino de la Serna J, Alonso C, Zasadzinski J, Perez-Gil, J, Pediatric Research, 1/1/2004
• Hyaluronan prevents surfactant inactivation.
  Lu K, Taeusch HW, Western Society for Pediatric Research, 1/1/2003
• Beneficial effects of adding dextran to Curosurf in a rat model of meconium aspiration.
  Taeusch HW, Lu K, Biol of the Neonate; Curosurf Surfactant Conference, Sardinia, 5/1/2002
• Dextran added to Curosurf for treatment of acute lung injury caused by meconium.
  Lu, K, Taeusch HW, J of Investigative Med, 1/1/2002
• Dextran-Curosurf treatment of meconium lung injury.
  Lu K, Taeusch HW, Pediatric Research, 1/1/2002
• Beneficial effects of adding dextran to Curosurf in a rat model of meconium aspiration.
  Taeusch, H. and K. Lu, Biol of the Neonate, 1/1/2002
• Polymer effects differ with Survanta, Curosurf, and Infasurf.
  Lu K, Taeusch HW, Journal of Investigative Med., 1/1/2001
• Polymer-surfactant therapy for adult rats with acute lung injury induced by saline lavage.
  Dehority W, Lu KW, Clements JA, Goerke J, Taeusch HW, American Review Respiratory & Critical Care Medicine, 1/1/2001
• Polymer/surfactant mixtures improve treatment of acute lung injuries in rats.
  Taeusch HW, Lu K, Allen L, Goerke J, Clements JA, Amer Rev Resp & Crit Care Med., 1/1/2000
• Polyethylene glycol enhances surfactant treatment of acute lung injury from meconium.
  Taeusch HW, Lu K, Goerke J, Clements JA, Pediatric Research, 4/1/1999
• Polyethylene glycol (PEG) results in concentration-dependent sedimentation of Survanta and improvement of its function.
  Sarin P, Taeusch HW, Lu K, Goerke J, Clements JA, Pediatric Research, 4/1/1999
• Join now to see all

Lectures

• Grand Rounds, Surfactant Treatment for Acute Lung Diseases: Exploring the Future. 
  Carmel Hospital, Haifa - 5/1/2014
• Presentation, Europediatrics 
  Barcelona - 10/1/2006
• Invited speaker Curosurf Annual Surfactant Conference 
  Vienna - 5/1/2004
• Pediatric/medicine postgraduate course on lung injury. 
  Lecco, Italy - 9/1/2003
• Invited speaker, Shanghai postgraduate course on neonatal lung disease 
  10/1/2002
• Invited speaker, Curosurf International Annual Surfactant Conference 
  Sardinia - 5/1/2002
• 1st Annual Barry Smith Memorial Lecturer 
  Queens University, Kingston, Ontario - 5/1/2002
• Lecturer, UCSF Obstetric Anesthesiology Annual Postgraduate Course 
  3/1/2002
• Invited Lecturer, Dept of Pediatrics, Cedars Sinai 
  Los Angeles, CA - 3/1/2002
• Invited speaker, Tufts University Update on Surfactant Replacement Symposium 
  Boston - 10/1/2001
• 3rd Nils W Svenningsen Memorial Lecturer, 15th International Workshop on Surfactant Replacement 
  Kos, Greece - 1/1/2000
• Invited speaker, Postgraduate symposium 
  Aghia Sophia Children's Hospital, Athens - 1/1/2000
• 5th International Marburg Symposium Surfactant and Alveolar Biology 
  Marburg, Germany - 9/1/1998
• Invited Speaker, “Surfactant Therapy: Then and Now” 
  Cincinnati, OH - 6/1/1998
• Invited Speaker, 80th Anniversary Vienna Kinderlklinik Glanzing 
  6/1/1995
• Speaker, NIH Consensus Conference on Use of Prenatal Corticosteroids to Prevent RDS 
  Washington, DC - 2/1/1994
• Keynote speaker, UCSF Retreat for Pulmonary Research 
  Asilomar - 9/1/1993
• Invited speaker, 7th Congress Asia/Oceania Perinatal Societies 
  Bangkok, Thailand - 10/1/1992
• Join now to see all

Other

• Israel Short Stories (anthology) Security Line; Master of the Universe 
  Taeusch HW
  1/1/2011
• Roll Playing. 
  Taeusch HW, Ilanot Journal
  1/1/2010
• Learning the Game. 
  Taeusch HW, Lulu.com
  1/1/2008
• Motherstuff. Epicenter. A Literary Periodical. 
  Taeusch HW
  7/1/2007
• Man Crying on a Subway. 
  Taeusch HW, Hurricane Review
  Pensacola - 1/1/2007
• Judy’s Circ. 
  Taeusch HW, Southern Indiana Review
  Evansville, IN - 10/1/2006
• Jack and Jill: A Reassessment Using Computer Modeling to Predict Outcomes. 
  Taeusch HW, Manhattan Literary Review
  New York - 1/1/2004
• Neonatal Asphyxia. (Film) 
  Taeusch HW, Peckham G, Mead Johnson Co.
  Evansville, IN - 1/1/1982
• Reduction of surfactant inactivation in pulmonary surfactant therapy. 
  Taeusch HW, U.S. Patent No. 09/138,435
• Website 
  Taeusch HW
  http://www.amazon.com/-/e/B001ITVQC8
• Join now to see all